Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Sunil Healthcare Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Sunil Healthcare Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sunil Healthcare Q2 net profit zooms 2533.33% at Rs 0.79 cr

    4 Nov 2025, 7:41PM The company reported standalone net profit of Rs 0.79 crore for the quarter ended September 30, 2025 as compared to Rs 0.03 crore in the same period l
  • Sunil Healthcare - Board Meeting Outcome for Outcome Of Board Meeting Held On 04.11.2025

    4 Nov 2025, 6:45PM Board of Directors at its meeting held today on 04.11.2025 interalia approved un-audited financial results(both standalone and consolidated) for the q
  • Sunil Healthcare - Unaudited Financial Results (Both Standalone And Consolidated) For The Quarter/Half Tear Ended 30.09.2025

    4 Nov 2025, 6:41PM Board of Directors at its meeting held today on 04.11.2025 interalia approved Unaudited Financial results (both standalone and consolidated) for the q
  • Sunil Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    11 Oct 2025, 7:05AM As of September 2025, 73.53% is owned by Indian Promoters and 26.47% by Public. <p align=justify> Top three Promoters holding highest number of shares
  • Sunil Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Oct 2025, 3:03PM Compliance Certificate under Regulation 74(5) of of SEBI (DP) Regulations, 2018 for the 2nd quarter ended 30.09.2025
  • Sunil Healthcare - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2025, 3:58PM Declaration of results alongwith scrutinizers' report of the 51st annual General Meeting of the Company held on September 29, 2025 pursuant to Regulat
  • Sunil Healthcare - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2025, 3:58PM Declaration of results alongwith scrutinizers' report of the 51st annual General Meeting of the Company held on September 29, 2025 pursuant to Regulat
  • Sunil Healthcare - Shareholder Meeting / Postal Ballot-Outcome of AGM

    29 Sep 2025, 4:02PM Proceedings of 51st Annual General Meeting of the Company held on 29th September 2025 pursuant to Regulation 30 of SEBI (LODR) Regulations
  • Sunil Healthcare - Reg. 34 (1) Annual Report.

    3 Sep 2025, 6:23PM ANNUAL REPORT FOR THE FINANCIAL YEAR 2024-25
  • Sunil Healthcare - Notice Of 51St Annual General Meeting Of The Company, Remote E-Voting Facility/E-Voting Facility And Other

    3 Sep 2025, 5:38PM 51st Annual General Meeting of the Company scheduled to be held on Monday, 29th September 2025 at 12.30 P.M. through video conferencing /other audio
  • Sunil Healthcare - Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares

    28 Aug 2025, 4:58PM Special Window for Re-lodgement of Transfer Requests of Physical Shares

Key fundamentals

Evaluate the intrinsic value of Sunil Healthcare Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 142.2971 140.1949 96.9397 89.0123 91.9795
Liabilities 142.2971 140.1949 96.9397 89.0123 91.9795
Equity 10.2548 10.2548 10.2548 10.2548 10.2548
Gross Profit 11.8697 4.2842 19.3069 17.8114 6.1502
Net Profit 0.2051 -2.1078 6.9769 6.7768 0.2753
Cash From Operating Activities 11.5375 -14.3492 7.1288 21.8933 16.6296
NPM(%) 0.24 -2.35 6.23 5.82 0.3
Revenue 83.4211 89.6875 111.8295 116.3729 89.6311
Expenses 71.5514 85.4033 92.5226 98.5615 83.4809
ROE(%) 0.3 -3.12 10.33 10.03 0.4

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sunil Healthcare Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 872.25 2.51 78.90 42.98 301.39 0.57
Lotus Eye Hospital and Institute Ltd 117.95 -0.04 379.32 156.60 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 20.43 1.04 0.00 325.15 -39.50 0.00
Astec Lifesciences Ltd 618.25 0.02 0.00 147.67 -604.77 0.00

Company Info

Sunloc, a leading brand of Empty Hard Gelatin Capsules, comes from Sunil Healthcare Ltd. Having started its operations over four decades ago, is the second largest manufacturer of EHGC in India and enjoys immense credibility in various global markets. Established in 1976 Located in Alwar (Rajasthan), 100 miles south of New Delhi, Capital of India. 2nd largest empty hard-shell gelatin (EHG) capsule producer in India. Introduced double-lock, triple lock and multi groove Capsules. Production capacity of 10.25 billion capsules/year on 22 fully automatic production lines. GMP Certificate as per NSF/IPEC/WHO-GMP/ANSI 363 Guideline & USFDA Certif¡cate - DMF No. - 18735, TYPE IV. 2014 -Sunil Healthcare Ltd shares are listed and admitted to dealings on the Exchange -Sunil Healthcare Limited (SHL) has been bestowed with the award for "Outstanding Contribution to Indias Pharmaceutical Exports during the year FY 2012-2013. 2015 -ICRA upgrades long term rating of Sunil Healthcare to BBB -Sunil Healthcare Ltd has "Award for the Best Use of Six Sigma in Healthcare by ABP News". 2016 -Sunil Healthcare sets-up wholly owned subsidiary in USA by the name of Sunil Healthcare North America LLC. 2017 -The company's Food Division has been awarded the prestigious 'Export Award' as 'Top Most Exporter under Cashew nut and Allied products from New Delhi.

Sunloc, a leading brand of Empty Hard Gelatin Capsules, comes from Sunil Healthcare Ltd. Having started its operations over four decades ago, is the second largest manufacturer of EHGC in India and enjoys immense credibility in various global markets. Established in 1976 Located in Alwar (Rajasthan), 100 miles south of New Delhi, Capital of India. 2nd largest empty hard-shell gelatin (EHG) capsule producer in India. Introduced double-lock, triple lock and multi groove Capsules. Production capacity of 10.25 billion capsules/year on 22 fully automatic production lines. GMP Certificate as per NSF/IPEC/WHO-GMP/ANSI 363 Guideline & USFDA Certif¡cate - DMF No. - 18735, TYPE IV. 2014 -Sunil Healthcare Ltd shares are listed and admitted to dealings on the Exchange -Sunil Healthcare Limited (SHL) has been bestowed with the award for "Outstanding Contribution to Indias Pharmaceutical Exports during the year FY 2012-2013. 2015 -ICRA upgrades long term rating of Sunil Healthcare to BBB -Sunil Healthcare Ltd has "Award for the Best Use of Six Sigma in Healthcare by ABP News". 2016 -Sunil Healthcare sets-up wholly owned subsidiary in USA by the name of Sunil Healthcare North America LLC. 2017 -The company's Food Division has been awarded the prestigious 'Export Award' as 'Top Most Exporter under Cashew nut and Allied products from New Delhi.

Read More

Parent Organisation

Sunil Healthcare Ltd.

Founded

05/02/1973

Managing Director

NSE Symbol

FAQ

The current price of Sunil Healthcare Ltd is

The 52-week high for Sunil Healthcare Ltd is

The market capitalization of Sunil Healthcare Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Sunil Healthcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Sunil Healthcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sunil Healthcare Ltd shares.

The CEO of Sunil Healthcare Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT